Myelodysplastic syndromes: update and nursing considerations
CPD Previous     Next

Myelodysplastic syndromes: update and nursing considerations

Mary Kelly Advanced nurse practitioner (haematology), Midland Regional Hospital, Tullamore, Offaly, Ireland
Teresa Meenaghan Advanced nurse practitioner (haematology), Galway University Hospitals, Ireland
Maura Dowling Lecturer, School of Nursing and Midwifery, National University of Ireland, Galway

This article provides nurses with an update on diagnosis, management and care of patients with myelodysplastic syndromes (MDS), a complex group of disorders of the bone marrow. MDS has wide-ranging effects on patients’ lives. Understanding the effect of a diagnosis of MDS on patients’ quality of life is an important part of the nursing role and includes consideration of physical, mental, emotional and social wellbeing. Many treatment options are available and nurses can educate patients on recognising and managing side effects. While there have been promising developments in management, nurses should ensure that patients and their families have a realistic understanding of MDS and ensure that they are aware that treatments other than haematopoietic stem cell transplantation are non-curative.

Cancer Nursing Practice. 14, 4,28-37. doi: 10.7748/cnp.14.4.28.e1132

Correspondence

maura.dowling@nuigalway.ie

Peer review

This article has been subject to double-blind review and checked using antiplagiarism software

Conflict of interest

None declared

Received: 30 January 2015

Accepted: 01 April 2015